ALTREN SOLUTION 0.22%

Country: Canada

Language: English

Source: Health Canada

Buy It Now

Active ingredient:

ALTRENOGEST

Available from:

AURORA PHARMACEUTICAL, INC.

Dosage:

2.2MG

Pharmaceutical form:

SOLUTION

Composition:

ALTRENOGEST 2.2MG

Administration route:

ORAL

Units in package:

15G/50G

Prescription type:

Prescription

Therapeutic group:

SWINE (PIGS); HORSES

Product summary:

Active ingredient group (AIG) number: 0116940001

Authorization status:

APPROVED

Authorization date:

2021-08-19

Patient Information leaflet

                                version 04 Jan 2024
1 Litre bottle – Center Panel
1 Litre
DIN: 02519135
FOR VETERINARY USE ONLY
POUR USAGE VÉTÉRINAIRE SEULEMENT
PR
ALTREN®
SOLUTION 0.22%
Altrenogest Oral Solution / Solution Orale d’Altrénogest
2.2 mg/mL / 2,2 mg/ml
Oral Progestin/Progestatif oral
WARNINGS:
1.
HORSES:
This drug is not to be administered to horses that are intended to be
slaughtered for use in food.
2.
SWINE:
Treated animals must not be slaughtered for use in food for at least
42 days
after the latest treatment with this drug.
3.
SOME INDIVIDUALS SHOULD NOT HANDLE THIS PRODUCT. SEE PACKAGE ONSERT
FOR COMPLETE
WARNINGS.
4.
ALTRENOGEST IS READILY ABSORBED BY THE SKIN. AVOID CONTACT WITH SKIN
OR EYES AND
ORAL EXPOSURE. WHEN HANDLING THIS PRODUCT OR WHEN TOUCHING
CONTAMINATED
SURFACES OR EQUIPMENT, VINYL, NEOPRENE OR NITRILE PROTECTIVE GLOVES
MUST BE WORN.
LATEX GLOVES ARE NOT PROTECTIVE. ANY EQUIPMENT OR SURFACES THAT COME
IN CONTACT
WITH ALTREN® SHOULD BE ADEQUATELY CLEANED AND DECONTAMINATED TO
PREVENT HUMAN
EXPOSURE.
5.
Women of childbearing age should exercise extreme caution when
handling this
product. Accidental absorption could lead to a disruption of the
menstrual cycle.
6.
EFFECTS IN HUMANS HAVE BEEN REPORTED IN CASE OF ACCIDENTAL EXPOSURE.
MITIGATION
MEASURES ARE RECOMMENDED. SEE PACKAGE ONSERT FOR COMPLETE WARNINGS.
7.
SEE PACKAGE ONSERT FOR EFFECTS OF OVEREXPOSURE.
8.
KEEP OUT OF REACH OF CHILDREN.
version 04 Jan 2024
1 Litre bottle – Left Panel
HORSES
INDICATIONS:
For suppression of estrus in mares.
DOSAGE AND ADMINISTRATION:
Administer orally at the rate of 1mL per 50 kg (110
lbs) body weight (0.044 mg/kg) once daily for 15 consecutive days. See
attached onsert for
complete details.
SWINE
INDICATIONS:
For suppression of estrus in sexually mature gilts.
DOSAGE AND ADMINISTRATION:
Top dress on gilts daily ration at the rate of 6.8 mL
(15 mg) per gilt per day for 14 consecutive days.
STORAGE:
Store between 15 and 30°C. Protect from freezing.
See attached onsert for complete information.
REORDER NO: 22003
Manuf
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet French 04-01-2024

Search alerts related to this product